{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-233450","form_type":"8-K","ticker":"SCLX","cik":"0001820190","company_name":"Scilex Holding Co","filed_at":"2025-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.602459+00:00","generated_at":"2026-05-17T04:28:46.653309+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Scilex appoints Stephen Ma as COO; he continues as CFO","bullets":["Stephen Ma, 53, appointed COO effective Oct 1, 2025; retains CFO, SVP, Corporate Secretary, and Board roles.","Ma has 15+ years finance/operations experience in pharma and venture-backed biotech.","Also appointed CFO of Semnur Pharmaceuticals (OTC:SMNR) on Sep 22, 2025.","No change in compensation for his COO appointment; standard indemnification agreement in place."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-233450","json":"https://secwatch.observer/filing/0001193125-25-233450.json","markdown":"https://secwatch.observer/filing/0001193125-25-233450.md","text":"https://secwatch.observer/filing/0001193125-25-233450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525233450/0001193125-25-233450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525233450/sclx-20251001.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:28:46.653309+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}